Skip to content

The Effect of a Blue Light Filtering IOL

The Effect of a Blue Light Filtering Intraocular Lens on Blood Retinal Barrier After Cataract Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00571831
Enrollment
50
Registered
2007-12-12
Start date
2003-02-28
Completion date
2005-03-31
Last updated
2007-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

to Compare the Effect of Two Types of IOLs, on the Incidence of Cystoid Macular Edema, After Cataract Surgery

Keywords

macula edema, intraocular lens, prospective randomized parallel clinical design

Brief summary

To compare the effect on blood retinal barrier disruption 3 and 12 months after implantation of either a blue light filtering intraocular lens(blue-filtering IOL) or an ultraviolet light filtering intraocular lens(UV-filtering IOL).

Detailed description

The following parameters were measured for evaluation of blood retinal barrier disruption. * the incidence of macular leakage by fluorescence angiography (FA) * the mean fluorescein concentration in the vitreous by fluorophotometry (VFP) * the thickness of the macula by optical coherence tomography (OCT) Results * the incidence fo macular leakage decreased significantly from 24%(3 months) to 5% (12 months) in the blue-filtering IOL group (P\<0.05), and was significantly lower compared with the UV-filtering IOL group at 12 months. * the VFP significantly decreased in both group from 3 to 12 months. * the OCT decreased from 175 (3 months) to 166 um (12 months) in the blue- filtering IOL group.

Interventions

Intraocular lens implantation

Sponsors

Showa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* cataract patients * All eligible for intraocular lens implantation

Exclusion criteria

* Patients had undergone an intraocular operation * Patients had hypertensive retinopathy * Patients had diabetic retinopathy * Patients had ange-related macular degeneration * no observable fundus * The cataract operation was more than 30 minutes in duration

Design outcomes

Primary

MeasureTime frame
To measure FA, VEP and OCT.At 3 and 12 months after IOL implantation

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026